Topiramate Tablet, Film Coated
Product Images NDC 50268-807

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 50268-807). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Product Formula For Topiramate (59862b94 C1fb 465a 9a53 Ad5174f9d129 01)

Chemical structure diagram of topiramate, illustrating its molecular composition with labeled oxygen, methyl, and sulfonamide groups consistent with the generic drug topiramate.*

FDA Label Image

Structured Product Formula For Topiramate (59862b94 C1fb 465a 9a53 Ad5174f9d129 02)

A Kaplan-Meier plot showing cumulative rates for time to first seizure over 500 days comparing Topiramate 50 mg/day and 400 mg/day. The graph displays two lines: a solid line for 50 mg/day (N=234) and a dashed line for 400 mg/day (N=236), with a p-value of 0.0002 indicating a statistical comparison.*

FDA Label Image

Topiramate Tablets Usp (59862b94 C1fb 465a 9a53 Ad5174f9d129 03)

A bar graph depicting the change from baseline to double-blind phase in average monthly migraine period rate (± standard error) for placebo and topiramate at doses of 50 mg/day, 100 mg/day, and 200 mg/day. The graph compares results from Study 11 and Study 12, showing greater reduction in migraine rate with increasing topiramate dose compared to placebo, with statistical significance indicated for higher doses.*

FDA Label Image

1 (806 15)

Topiramate Tablets, USP 25 mg film-coated tablets with NDC 50268-806-15. The label indicates Rx only, available in a unit dose package of 50 tablets (5 packs of 10). The label features dosage information, storage instructions at 20° to 25°C, and a reminder to keep medication out of children's reach. It is manufactured for AvKARE and labeled with the AvPAK logo.*

FDA Label Image

1 (807 15)

Label for Topiramate Tablets USP 50 mg oral film-coated tablets by AvPAK. The label shows the product name, strength (50 mg), quantity (50 tablets, 5 blister packs of 10), and Rx only status. It includes storage instructions, pharmacist dispensing details, manufacturer information, and a barcode with NDC 50268-807-15.*

FDA Label Image

1 (808 15)

Label for Topiramate Tablets, USP 100 mg film-coated tablets by AvPAK. The package contains 50 tablets in unit doses (5 x 10). The label includes instructions to dispense a medication guide, storage conditions, manufacturer information for AvKARE, and barcodes.*

FDA Label Image

1 (809 15)

Label for Topiramate Tablets, USP 200 mg film-coated tablets. The label shows the product name, strength (200 mg), dosage form, and quantity (50 tablets, 5 x 10 unit dose). Manufacturer information is AvPAK, with a manufacturing location listed as Pulaski, TN. The label includes storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.